Global Pharmaceutical Leader
Advancing the Biology of Potential.
Harnessing generative biotechnology and molecular intelligence to solve the world's most complex healthcare challenges.
Research & Development
Precision Medicine, At Scale.
Our AI-native R&D engine accelerates drug discovery from years to months, identifying high-affinity molecules with unprecedented precision.
Neural-Proteomics
Decoding protein interactions through high-fidelity neural network modeling to target previously "undruggable" pathologies.
Synthetic Genomics
Engineering programmable RNA therapeutics that respond dynamically to cellular environments.
Clinical Digital Twins
Simulating patient response profiles to optimize clinical trial outcomes and patient safety protocols.
Therapeutic Pipeline
Active Development Portfolio
SY-402 (Oncology)
Next-gen CAR-T Cell Therapy
SY-109 (Neurology)
Amyloid Plaque Inhibitor
SY-882 (Immunology)
Monoclonal Antibody
Ethics & Governance
A Global Standard for Trust.
Operating with absolute integrity across 85 countries. Our governance framework exceeds FDA, EMA, and PMDA requirements, ensuring global health equity and patient safety.
Net Zero 2035
Committed to carbon-neutral manufacturing across all facilities.
ESG AA Rating
Top-tier environmental and social governance performance.